Ignite Creation Date:
2025-12-24 @ 5:32 PM
Ignite Modification Date:
2026-02-22 @ 9:04 AM
Study NCT ID:
NCT02482168
Status:
COMPLETED
Last Update Posted:
2023-12-20
First Post:
2015-06-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the CD40 Agonistic Monoclonal Antibody APX005M
Sponsor:
Apexigen America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APX005M-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None